Home › Funds › Karpus Management, Inc. › DMAA

Karpus Management, Inc. position in DMAA

DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05 · Financials

Karpus Management, Inc. reported holding 2,493,683 shares of DMAA (DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 0.82% of its reported portfolio and ranking #27 among its reported holdings. Karpus Management, Inc. has disclosed DMAA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)2.49M sh
Reported value held$26.93M
Portfolio Weight0.82%
First reportedQ1 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Karpus Management, Inc.'s DMAA position evolved

Karpus Management, Inc. first disclosed a stake in DMAA in Q1 2025 at 2,324,034 shares (US$23.3M). The position peaked in Q2 2025 at 2,744,109 shares, worth US$28.0M. Across 7 filings, Karpus Management, Inc. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,493,683 shares valued at US$26.9M — a reduction of -14,134 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 2.32M $23.29M New
Q2 2025 2.74M $27.99M Add
Q3 2025 2.55M $26.16M Reduce
Q4 2025 2.54M $26.33M Hold
Q1 2026 2.53M $26.52M Hold
Q2 2026 2.51M $26.71M Reduce
Q3 2026 2.49M $26.93M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMAA and 13F data

DMAA (DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05) is a Financials company. 24 other funds we track also report a position in DMAA — the largest reported positions include MIZUHO SECURITIES USA LLC (US$40.6M), First Trust Capital Management L.P. (US$8.6M), HEIGHTS CAPITAL MANAGEMENT, INC (US$6.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMAA

All DMAA fund holders →

FAQ

How long has Karpus Management, Inc. held DMAA?

Karpus Management, Inc. has disclosed DMAA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Karpus Management, Inc.'s current position in DMAA?

As of Q3 2026, Karpus Management, Inc. holds 2.49M shares of DMAA (DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05), valued at $26.93M, representing 0.82% of its reported portfolio and ranking #27.

Has Karpus Management, Inc. been buying or selling DMAA?

In the latest 13F filing (Q3 2026), Karpus Management, Inc. reduced its position in DMAA. The position peaked in Q2 2025 at 2.74M shares.

Which other funds hold DMAA?

Other major institutional holders of DMAA include MIZUHO SECURITIES USA LLC, First Trust Capital Management L.P., HEIGHTS CAPITAL MANAGEMENT, INC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.